ERBB2 and breast cancer: In a previous study, we have shown that a gain in the CEP17 copy number is an indicator of poor prognosis in patients with luminal/HER2-negative breast cancers, suggesting that CEP17 copy number gain may reflect chromosomal instability (CIN) in breast cancer10.